# Metabolic and Neuro-Endocrine Effect of Treating PCOS in Adolescents

> **NCT03981861** · PHASE2,PHASE3 · COMPLETED · sponsor: **Children's Mercy Hospital Kansas City** · enrollment: 12 (actual)

## Conditions studied

- PCOS

## Interventions

- **DRUG:** Metformin and Spironolactone

## Key facts

- **NCT ID:** NCT03981861
- **Lead sponsor:** Children's Mercy Hospital Kansas City
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-02
- **Primary completion:** 2018-07-09
- **Final completion:** 2019-06-05
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2021-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03981861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03981861, "Metabolic and Neuro-Endocrine Effect of Treating PCOS in Adolescents". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03981861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*